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Abstract：Immune cells normally attack exogenous bacteria or viruses without harming the body's 
cells or tissues. However, any abnormality in these immune cells could consequently result in cell 
or tissue damage of various organs, including the pancreas, salivary glands, and joints as the targets 
of autoimmune diseases. Autoimmune diseases result from complex and multigenic phenotypes that 
affect by a variety of genetic and environmental or stochastic factors. Fundamental treatments for 
autoimmune diseases have not yet been established. In this review, we introduce the following: (1) 
useful animal models for Sjögren's syndrome (SS), (2) the critical role of estrogen in autoimmunity, (3) 
the influence of environmental hormones on autoimmunity, (4) the cell signaling in autoimmunity, and 
(5) the therapeutic strategy for autoimmune disease.
徳島大学大学院ヘルスバイオサイエンス研究部口腔分子病態学分野
















































る 10, 11）。さらに，nuclear factor （NF）-κB-inducing kinase 
（NIK）遺伝子の点変異マウスとして全身のリンパ節を




子欠損マウス，autoimmune regulator （AIRE） 遺伝子欠損


































































































ナイーブ T細胞を用いて NF-κB2分子が NF-κB1分子と
結合することによって，T細胞の細胞質内で NF-κBが
制御されていることが明らかになった 41）。aly/alyマウス
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